Mycobacterium avium is one of the most prevalent opportunistic infections in AIDS patients, and neither prophylaxis nor treatment against M. avium is effective. To evaluate host defense mechanisms against mycobacterial infections, studies investigated whether neutrophils from AIDS patients could inhibit the growth of M. avium in vitro and what cytokines enhance neutrophil function against M. avium. Peripheral blood neutrophils from human immunodeficiency virus -negative and AIDS patients were incubated with media, granulocyte colony-stimulating factor (G-CSF), granulocytemacrophage colony-stimulating factor (GM-CSF), interleukin-8, or macrophage-inhibitory proteins and infected with M. avium, and the inhibition of bacterial growth was determined. G-CSF (1000 U/mL) and GM-CSF (2000 U/mL) stimulated neutrophils from AIDS patients to significantly inhibit M. avium growth. These results demonstrate that neutrophils from AIDS patients can respond to exogenously supplied G-CSF or GM-CSF by inhibiting the growth of M. avium.
The neutrophil is one of the first cells involved in mediating tribute to the initial host inflammatory responses to M. avium infection and, thus, may be a primary factor in resistance to innate host resistance to both bacterial and fungal infections, and the interactions with neutrophils and mycobacteria are infection by M. avium in immunocompetent persons. AIDS-associated neutrophil disorders may place these patients thought to be important in initiating general host resistance against mycobacterial infection. In mouse strains susceptible at risk for developing mycobacterial infections, which occur in ú60% of AIDS patients, leading to morbidity and mortality [6, to Mycobacterium avium infections, neutrophil infiltrates are reduced compared with infiltrates in resistant mice following 7]. Many AIDS patients are neutropenic, resulting from human immunodeficiency virus (HIV) infection itself [8] or secondarily intraperitoneal inoculation of M. avium [1] . Furthermore, macrophages within the regional lymph nodes and lungs in M.
to the side effects of zidovudine or ganciclovir treatment or both [9, 10] , and this neutropenia may render these patients more avium -infected mice contain large numbers of intracellular acid-fast bacteria and neutrophil-derived lactoferrin [2, 3] . Neususceptible to M. avium and other opportunistic infections. In addition to neutropenia, neutrophil function may also be trophils may, thus, facilitate macrophage-mediated killing of mycobacteria by initially phagocytizing M. avium, causing pardiminished by HIV infection, although it remains controversial as to whether their function in AIDS patients is defective [8] . tial degradation of the bacteria and releasing enzymatic granAlternatively, insufficient production of cytokines modulating ules that macrophages then phagocytize, thereby increasing the neutrophil function may be the underlying cause of decreased macrophage's effectiveness in eliminating the bacteria [2] . In neutrophil activity. The cytokines granulocyte colony-stimulatvitro systems using human neutrophils have shown that isolated ing factor (G-CSF), granulocyte-macrophage colony-stimulatneutrophil molecules, defensins, kill M. avium [4] , and activaing factor (GM-CSF), interleukin (IL)-8, and macrophage-intion of neutrophils enhances killing of Mycobacterium tubercuhibitory proteins (MIPs) have been shown to mediate effective losis [5] , indicating that human neutrophils appear to have antimycobacterial activity by recruiting neutrophils and inantimycobacterial capabilities. Neutrophils are thought to concreasing their bactericidal activity against mycobacteria [11 -13] . HIV infection is known to either reduce or increase the amounts of cytokines produced by macrophages [14] , and we JID 1997; 175 (April) cultured for 5-7 days in complete IMDM. The nonadherent cells
Methods
were removed by two vigorous washings with HBSS, and then Donor and patient characteristics. Seven healthy HIV-negafresh medium was added to the cultures. By 7 days, a complete tive donors used for this study were skin-tested and were tubercumonolayer was present, which contained Ç10 5 adherent cells, of lin-negative. This group consisted of 5 men and 2 women with a which 98%-100% were macrophages, as demonstrated by nonspemean ({SD) age of 37 { 10 years.
cific esterase staining. The HIV-positive patient population was composed of 31 men
Growth of M. avium. Virulent stocks of M. avium were mainand 4 women with a mean ({SD) age of 34.5 { 11 years. Each tained by passaging M. avium, serovar 4, in cultures of human person had AIDS: The mean ({SD) CD4 T cell count was 79.2 macrophages. M. avium was plated from macrophage cultures, and { 98 cells/mm 3 (range, 0-280). Thirty-two persons (92%) had an smooth transparent colony types were selected for growth in broth. AIDS-defining illness that was first diagnosed a mean of 9 { 14
The organisms were cultured for 10-14 days in Middlebrook 7H9 months before the study. These illnesses included: Pneumocystis broth (Difco, Detroit) made with endotoxin-free water (Baxter carinii pneumonia (11 patients), candidal esophagitis (9 patients), Healthcare) containing albumin, dextrose, and catalase (Difco). cerebral toxoplasmosis (3 patients), cytomegalovirus retinitis (3 The organisms were harvested, centrifuged, and washed twice in patients), Kaposi's sarcoma (2 patients), cryptococcal meningitis HBSS. The cells were resuspended in fresh 7H9 broth, aliquoted, (2 patients), recurrent bacterial infections (1 patient), and crypand frozen at 070ЊC. An aliquot was thawed and plated in Midtosporidiosis (1 patient). No patient had documented infection due dlebrook 7H11 agar with oleic acid, albumin, dextrose, and catato M. avium, and all patients had negative cultures for this organism lase (Difco) to enumerate organisms per milliliter of medium. 6 months before the study or immediately after it. Twenty-nine
Infection of neutrophils, PBMC, and macrophages with M. patients (80%) were receiving antiretroviral therapy at the time of avium and monitoring of bacterial growth. Neutrophils and the study; this included zidovudine monotherapy (12 patients), PBMC were inoculated with M. avium immediately after isolation didanosine monotherapy (9 patients), and combination therapy from peripheral blood, while macrophages were infected after 7 with zidovudine plus didanosine (5 patients) or zidovudine plus days of in vitro culture. Isolated neutrophils or PBMC were plated zalcitabine (3 patients). Thirty-three persons (94%) were receiving at a concentration of 10 6 cells/well in a 48-well plate. All cells prophylaxis against P. carinii pneumonia, and the regimens inwere inoculated with 10 6 M. avium/well. Individual cytokines were cluded trimethoprim-sulfamethoxazole (16 patients), dapsone (14 then immediately added to the M. avium -infected neutrophils, and patients), or aerosolized pentamidine (4 patients). Five patients the cells were incubated for various time periods. The growth of were receiving prophylaxis against M. avium infection.
M. avium in tissue culture medium without cells was also deterCytokines and cytokine ELISAs. Recombinant (r) G-CSF (acmined by adding 10 6 organisms to 0.5 mL of complete medium tivity: 5000 pg/mL Å 150 U/mL) and a truncated placebo form in a 48-well plate. ing the pellet twice in HBSS and then lysing the red blood cells tissue culture flasks (Costar) with vented caps at a concentration of by adding 0.2% NaCl. The cells were washed three times with 10 7 cells/flask. The macrophages were isolated by adherence to HBSS to remove the red blood cell debris and restore isotonicity.
plastic for 4-5 days, and the nonadherent mononuclear cells were The neutrophils were resuspended in complete IMDM and removed by two vigorous washings with HBSS. Fresh IMDM was counted. The preparations contained between 95% and 98% neuadded, and the cells were incubated for a total of 7 days before trophils identified by Wright's stain.
infection with HIV-1. Macrophages were isolated by adherence to culture plates. and Reference Repository), a monocytotropic strain of HIV-1. Supernatants from infected macrophages were pooled, and the amount of HIV-1 was titered by diluting the stocks and reinfecting human macrophages with the different dilutions. The amount of virus was determined by the amount of p24 present in the supernatants of infected macrophages using an ELISA (NEN/DuPont Research, Cambridge, MA). Stock HIV-1 for these experiments was titered at a TCID 50 of 5.25, and macrophages were infected at an MOI of 0.1-0.01. Macrophages were infected with stock HIV-1 for 4 h at 37ЊC. The monolayers were then washed three times with HBSS, and fresh IMDM was added to the cells. The macrophage cultures were incubated for a total of 14 days before stimulation with M. avium or LPS, which allows chronic HIV-1 infection to occur. After the 14 days, the macrophages were stimulated with M. avium at a ratio of 10 organisms/cell or LPS (Escherichia coli O55:85) (Sigma, Figure 1 . Inhibition of growth of M. avium by different populations St. Louis) at a concentration of 100 ng/mL. The supernatants were of peripheral blood cells from HIV-negative donors. M. avium was harvested at various times after stimulation, filtered through a 0.22-incubated with no cells, Iscove's modified Dulbecco's medium only mm filter, and stored at 070ЊC until assayed for the presence of (᭺), isolated neutrophils, 10 6 (᭡), isolated peripheral blood mononu-G-CSF or IL-8 by ELISA.
clear cells, 10 6 (), or 7-day cultured adherent macrophages, 10
5
Effects of macrophage supernatants on the ability of neutrophils (ࡗ). Cells were harvested 1, 4, 7, or 10 days after infection; amount to inhibit growth of M. avium. Supernatants from HIV-infected of M. avium was determined by radiometric Bactec 460TB system. and uninfected treated macrophages, as described above, were Data are mean { SD of triplicate samples and represent experiments using 3 different healthy donors. added to freshly isolated neutrophils from HIV-negative donors at dilutions of 1:2 and 1:4. The neutrophils were then infected with M. avium at a ratio of 1:1; cells were incubated for 4 days before harvesting to determine the amount of bacteria present. growth inhibition of M. avium growth (figure 2). In contrast to the effect of G-CSF on neutrophil function against M. avium, MIP-2b, at concentrations of 200, 100, and 50 U/mL, signifiResults cantly enhanced growth of M. avium (P Å .0001, .0001, and .001, respectively) (figure 3). No significant differences in M. avium growth is inhibited when cultured in the presence of neutrophils. To compare the differences in growth inhibigrowth reduction of M. avium were seen between monocyteor endothelial cell -derived IL-8. Of the 7 HIV-negative donors tion of M. avium by untreated neutrophils, PBMC, and macrophages, the different peripheral blood cell populations were tested, 6 responded to G-CSF treatment.
In kinetic experiments, we also investigated G-CSF -mediinfected with M. avium. Growth of M. avium was monitored to determine which cell population would best inhibit its ated inhibition of M. avium growth by neutrophils from HIVnegative donors. Neutrophils were incubated with rG-CSF or growth. The neutrophils significantly inhibited the growth of M. avium at 7 days after infection compared with both PBMC rGM-CSF at concentrations of 2000 U/mL or medium alone and with M. avium. Maximal differences in the growth of M. (P Å .000) and macrophages (P Å .043) (figure 1) when the cells were inoculated with the same amount of M. avium. avium occurred at 3 days after infection for all treatments (figure 4); therefore, in all other experiments, the neutrophils rG-CSF stimulates neutrophils to inhibit M. avium growth. To determine whether activation of the cells by various neutrowere incubated with M. avium for 3 days before the cells and bacteria were harvested. phil-modulating agents could increase the M. avium growthinhibiting response, neutrophils were incubated with various G-CSF enhances neutrophil viability. Viability of G-CSFtreated neutrophils was examined as a mechanism of growth concentrations of the following factors: rG-CSF, GM-CSF, IL-8 (either monocyte-or endothelial cell -derived), or MIP-1a, inhibition of M. avium. G-CSF significantly enhanced neutrophil viability in both M. avium -infected and noninfected cells -1b, -2a, or -2b. Cells were incubated in the presence of the cytokines and M. avium for 3 days before being harvested. Of at 24 h after infection (table 1) also significantly enhanced neutrophil viability in cells not inof infected neutrophils were observed between any of the treatment groups. fected with M. avium at 1000, 2000, and 4000 U/mL (P Å .001, .001, .0001, respectively) compared with non -G-CSF -G-CSF enhances neutrophils from AIDS patients to inhibit the growth of M. avium. We then investigated whether G-CSF also treated cells (table 1) . By 48 h, viability of both treated and untreated neutrophils was õ10%. No significant difference in stimulated neutrophils from AIDS patients to inhibit the growth of M. avium. Neutrophils were isolated and treated with various viability occurred between control noninfected and M. aviuminfected neutrophils at any time point.
concentrations of G-CSF, GM-CSF, or monocyte-derived IL-8. No significant differences were observed between cells from HIVneutrophils did not respond to any concentration of cytokine. Clinical data from a total of 10 patients were examined, 4 respondnegative and -positive donors in the ability to kill M. avium with or without G-CSF treatment.
ers and 6 nonresponders. Responsiveness to G-CSF was not dependent on CD4 T cells, percentage of neutrophils, total number Neutrophils from 30 (86%) of 35 patients responded to G-CSF. It was of interest to determine whether different clinical of neutrophils, or neutrophils per milliliter of peripheral blood (table 2) . No statistical correlations were observed between reparameters would correlate with either responsiveness or nonresponsiveness to G-CSF. We examined the clinical data from the sponsiveness to G-CSF and age, ethnic background, risk factor for HIV infection, drug regimens, or existence of other opportunistic two extreme patterns of responsiveness: patients whose neutrophils responded to all concentrations of G-CSF and patients whose infections (table 3) . Of note, however, 4 of the 6 nonresponders but none of the G-CSF responders had clinical diagnoses of P. carinii infection.
M. avium and LPS induce increased production of G-CSF and IL-8 by HIV-infected macrophages.
Since G-CSF stimulated neutrophils from both HIV-negative and -positive donors to inhibit M. avium growth, it appeared that neutrophils from AIDS patients could respond to G-CSF and GM-CSF. We then investigated if in vivo susceptibility to M. avium infection was associated with a failure of cells to produce G-CSF or GM-CSF or both. Table 1 . % viability of neutrophils treated with different concentrations of granulocyte colony-stimulating factor (G-CSF) and infected with M. avium.. 
Supernatants from HIV-and M. avium -infected and HIVand LPS-treated macrophages do not augment neutrophil inhibition of M. avium growth.
Because both G-CSF and IL-8 were present in the supernatants of HIV-infected macrophages, we then determined if these supernatants could augment the reduction in M. avium growth by neutrophils isolated from HIV-negative donors. When these neutrophils were incubated with macrophage supernatants containing G-CSF, no enhancement or decrease in the growth of M. avium was seen. Although HIV-1 -infected macrophages produced significantly more G-CSF than did non -HIV-infected cells, the amount of G-CSF was considerably less, 88 -100 U/mL, than that required to activate neutrophils in vitro, 1000 -2000 U/mL.
Discussion
Disseminated M. avium infection is one of the most common opportunistic infections associated with AIDS [16] . M. avium Human macrophages were infected in vitro with HIV-1, then stimulated with either live M. avium, 1 organism per cell, or LPS, 100 ng/mL. Surprisingly, HIV infection increased the quantity and kinetics of production of both G-CSF and IL-8 induced by either M. avium or LPS over that of non -HIVinfected macrophages. HIV-infected cells stimulated with M. avium produced significantly more G-CSF, 2963 { 124 pg/ mL (mean { SD) (P Å .0001), for the longest period of time, 5 days, compared with LPS, 1265 { 125 pg/mL (figure 7). G-CSF was detectable in non -HIV-infected macrophage supernatants stimulated with M. avium at 5 days, but in low quantities, 339 { 20 pg/mL.
IL-8 was induced by M. avium and LPS in both HIV-infected and noninfected macrophages. The quantity and kinetics of IL- † Isolated neutrophils/mL of blood used for G-CSF studies. ‡ Mean { SE (n Å 7).
infections occur during late-stage HIV infection (with CD4 T down of host resistance to M. avium infection in AIDS patients are unclear but may involve innate host resistance mediated cell numbers usually õ100/mm 3 ), whereas M. avium is usually nonpathogenic in immunocompetent persons [16] . This organby neutrophil function. The results of our study indicate that neutrophils are capable of reducing the growth of M. avium. ism is ubiquitous, being found in air, soil, and local water supplies [17 -19] . The exact mechanisms involved in the breakTreatment of neutrophils with rG-CSF enhances the neutro- phil's ability to inhibit the growth of M. avium by increasing their viability or stimulating production of neutrophil antimicrobial agents (or both). It also appears that the function of neutrophils from most AIDS patients is at least partially intact, as assessed by their ability to inhibit the growth of M. avium and to respond to G-CSF treatment in vitro by an enhanced reduction of M. avium growth. Diminished host reactivity to M. avium may, therefore, be related to neutropenia associated with HIV-1 infection and could be augmented in vivo by G-CSF therapy.
Our findings that unstimulated neutrophils inhibit M. avium growth better than macrophages or other peripheral bloodderived cells is not surprising, as neutrophils contain many components that are absent in macrophages. Defensins, found only in neutrophils, were found to be bactericidal against M. avium -Mycobacterium intracellulare and effective even against virulent isolates from AIDS patients [4] . In patients with late-stage HIV-1 infection, the combined lack of CD4 T cells and neutrophils may increase their susceptibility to M. Mycobacterium fortuitum [12] , our studies indicate that IL-8 used to generate granulocyte colony-stimulating factor protein data in figure 7. has no effect on M. avium growth inhibition. This difference / 9d21$$ap29 02-21-97 18:08:26 jinfa UC: J Infect
In addition, the high concentrations of drugs required for anti-IL-1b [15] . Results of these studies now also demonstrate that induction of G-CSF and IL-8 by HIV-1 -infected macrophages mycobacterial activity are often toxic to the patient and result in discomfort [27] . stimulated with either M. avium or LPS is also significantly increased and therefore, HIV infection does not inhibit the Combined cytokine plus antibiotic therapy in the treatment of M. avium infections in AIDS patients may be of considerable production of neutrophil-stimulating factors by macrophages. These supernatants did not increase neutrophil antimycobactebenefit to the patient. Use of G-CSF with clarithromycin [28] and GM-CSF with azithromycin or amikacin [29] in mice has rial activity, possibly because of the low concentration of G-CSF present, Ç100 U/mL. In vivo, however, concentrations been effective in decreasing M. avium bacteremia. G-CSF in combination with quinolone has also been shown to enhance of cytokine produced locally and affecting neutrophils are probably much higher. resistance to infection in cancer patients [30] . Cytokine therapy combined with traditional antibiotics may increase the numbers G-CSF is used clinically to both increase neutrophil numbers and increase their viability while in circulation in both neutroof cells required to elicit a protective host response, thereby decreasing the amount of antibiotics required for effective penic cancer and AIDS patients. However, it has not been used specifically to improve host defense against microbial clearance of the bacteria. Specifically, the use of G-CSF in the treatment of M. avium infections could increase both the numinfections, although G-CSF has been shown to decrease the incidence of infections in neutropenic patients [10, 30, 46, 47] . bers and the half-life of circulating neutrophils [31] . Many of the antibiotics used to treat mycobacterial infections are taken G-CSF is well tolerated by AIDS patients with few side effects [31] , allows continuation of myelotoxic drugs [46, 47] , and up by phagocytes and exert their antimycobacterial activity intracellularly [32] . If the viability of the neutrophil in circuladoes not increase HIV replication [46, 47] . Use of G-CSF, therefore, in nonneutropenic AIDS patients at risk for M. avium tion was prolonged, the quantity of antibiotic administered could be decreased because its effect within the neutrophil infection warrants further consideration as a possible therapeutic agent. would be prolonged. In addition, the underlying cause of increased M. avium infections in AIDS patients may be the limited numbers of neutrophils able to effectively respond to M. avium infection rather than a functional defect of the neutrophil.
In addition, neutrophils from 22% of our AIDS patients did 
